COMPUGROUP MED.SE O.N.
stock DE:COP (FRANKFURT)

Alternative ID: DE0005437305 543730

Watch List

Exchange: FRANKFURT
Sector: Healthcare
Industry: Health Information Services
Market Cap: Mid (2.02B)
Data in EUR

EPS: 1.19
Current PE: 79.92
BVPS: 11.72
Price/BVPS: 8.47
Dividend: 0.50 / 1.3%

Hist Grade: B (70.46)
YOY Grade: D (38.64)
Debt/FCF: 7.18
ROIC: 4.9%
PEG: 2.55
PEGY: 2.45

Value Price: 150.63
MOS Price: 75.31
MOS %: 51.8%
Graham Number: 17.74
Graham MOS %: -82.1%
IRT: 11.24

Market Price

99.25

-0.50 -0.5%

as of Mar 30 '23

52 Week Range:

30.84 126.39

Stock Analyzer Tutorials

General Info

type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

Financial Statements

type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

Growth Grade and Financial Ratios

type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

Price Charts

type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Exchange: FRANKFURT
Sector: Healthcare
Industry: Health Information Services
Market Cap: Mid (2.02B)
Inst. Ownership: 30.17%
Insider Ownership: 50.30%
Full Time Employees: 8734

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement

Cash Flow Statement

Balance Sheet

Liquidity Ratios

Current Ratio

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Equity (BVPS)	3.34	3.65	3.58	3.98	3.79	4.12	4.69	5.04	5.46	11.76	11.72
growth rate		9.3%	-1.9%	11.2%	-4.8%	8.7%	13.8%	7.5%	8.3%	115.4%	-0.3%
Earnings BIT	25.20	48.37	57.37	45.05	72.79	82.86	87.57	141.65	115.95	120.19	106.63
growth rate		91.9%	18.6%	-21.5%	61.6%	13.8%	5.7%	61.8%	-18.1%	3.7%	-11.3%
Avg.PE	47.39	23.64	38.91	45.21	36.65	37.98	57.20	29.71	43.32	51.68	47.78
growth rate		-50.1%	64.6%	16.2%	-18.9%	3.6%	50.6%	-48.1%	45.8%	19.3%	-7.6%
ROA	1.53	4.75	3.47	3.71	5.04	5.57	3.83	11.04	6.88	5.56	4.11
growth rate		210.5%	-27.0%	6.9%	35.9%	10.5%	-31.2%	188.3%	-37.7%	-19.2%	-26.1%
ROE	5.23	17.68	12.57	14.37	20.80	21.72	13.83	36.57	24.84	16.31	11.03
growth rate		238.1%	-28.9%	14.3%	44.8%	4.4%	-36.3%	164.4%	-32.1%	-34.3%	-32.4%
ROIC	4.52	8.83	6.47	7.42	8.15	8.60	6.12	16.12	9.91	7.72	5.52
growth rate		95.4%	-26.7%	14.7%	9.8%	5.5%	-28.8%	163.4%	-38.5%	-22.1%	-28.5%
Cur. Ratio	0.70	0.62	0.93	1.01	0.85	0.94	0.98	1.10	0.99	1.06	0.93
growth rate		-11.4%	50.0%	8.6%	-15.8%	10.6%	4.3%	12.2%	-10.0%	7.1%	-12.3%
Quick Ratio	0.56	0.53	0.66	0.87	0.72	0.80	0.80	0.78	0.67	0.82	0.71
growth rate		-5.4%	24.5%	31.8%	-17.2%	11.1%	0.0%	-2.5%	-14.1%	22.4%	-13.4%
Leverage	3.81	3.63	3.62	4.14	4.12	3.71	3.52	3.13	4.11	2.45	2.93
growth rate		-4.7%	-0.3%	14.4%	-0.5%	-10.0%	-5.1%	-11.1%	31.3%	-40.4%	19.6%
Balance Sheet	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Acct.Receivable	72.00	71.00	77.35	105.38	120.03	125.40	124.46	131.40	142.49	194.47	221.14
growth rate		-1.4%	9.0%	36.2%	13.9%	4.5%	-0.8%	5.6%	8.4%	36.5%	13.7%
Acct.Payable	21.00	17.00	23.08	25.44	27.35	31.38	43.94	39.29	47.09	64.52	87.83
growth rate		-19.1%	35.7%	10.2%	7.5%	14.7%	40.0%	-10.6%	19.9%	37.0%	36.1%
Cur.Assets	107.00	107.00	124.59	142.46	164.89	170.44	177.95	192.81	232.93	308.11	370.78
growth rate		0.0%	16.4%	14.4%	15.8%	3.4%	4.4%	8.4%	20.8%	32.3%	20.3%
Total Assets	641.00	651.00	691.29	737.55	791.68	807.91	825.01	848.31	1,065.86	1,565.77	1,790.81
growth rate		1.6%	6.2%	6.7%	7.3%	2.1%	2.1%	2.8%	25.7%	46.9%	14.4%
Cash	24.00	19.00	23.45	21.47	25.06	27.76	30.36	25.30	46.35	75.91	107.34
growth rate		-20.8%	23.4%	-8.5%	16.7%	10.8%	9.4%	-16.7%	83.2%	63.8%	41.4%
Inventory	4.00	3.00	4.19	5.88	6.52	5.27	12.50	19.58	27.49	18.16	20.64
growth rate		-25.0%	39.5%	40.4%	10.9%	-19.1%	137.1%	56.7%	40.4%	-34.0%	13.7%
Cur.Liabilities	152.00	174.00	155.51	140.69	194.08	180.83	181.28	184.29	236.30	290.54	398.35
growth rate		14.5%	-10.6%	-9.5%	38.0%	-6.8%	0.3%	1.7%	28.2%	23.0%	37.1%
Liabilities	473.00	472.00	506.63	561.92	599.07	589.25	588.95	584.48	805.95	926.84	1,178.53
growth rate		-0.2%	7.3%	10.9%	6.6%	-1.6%	-0.1%	-0.8%	37.9%	15.0%	27.2%
LT Debt	241.00	235.00	286.00	342.86	324.76	327.34	326.09	318.85	424.46	470.20	587.08
growth rate		-2.5%	21.7%	19.9%	-5.3%	0.8%	-0.4%	-2.2%	33.1%	10.8%	24.9%
Equity	168.20	179.40	188.77	175.67	192.29	217.83	234.17	261.72	259.11	638.67	612.07
growth rate		6.7%	5.2%	-6.9%	9.5%	13.3%	7.5%	11.8%	-1.0%	146.5%	-4.2%
Common Shares	50.00	50.00	50.00	50.00	50.00	50.00	50.00	53.22	53.22	53.74	53.74
growth rate		0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	6.4%	0.0%	1.0%	0.0%
Cash Flow Statement	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Capital Expenditures	12.00	18.00	7.54	8.08	6.84	23.11	18.67	12.73	14.68	17.68	27.05
growth rate		50.0%	-58.1%	7.2%	-15.4%	238.1%	-19.2%	-31.8%	15.4%	20.4%	53.0%
Cash Dividends	12.60	12.50	17.37	17.40	17.40	17.40	17.40	17.40	24.41	24.21	26.37
growth rate		-0.8%	38.9%	0.2%	0.0%	0.0%	0.0%	0.0%	40.3%	-0.9%	8.9%
Cash From OA	47.00	67.00	52.33	31.94	73.25	67.61	85.82	136.35	110.50	149.93	165.27
growth rate		42.6%	-21.9%	-39.0%	129.3%	-7.7%	26.9%	58.9%	-19.0%	35.7%	10.2%
FCF per Share	0.44	0.82	0.58	0.48	0.46	0.63	0.97	1.47	1.66	1.69	1.54
growth rate		86.4%	-29.3%	-17.2%	-4.2%	37.0%	54.0%	51.6%	12.9%	1.8%	-8.9%
FCF	24.00	40.00	28.00	7.00	49.00	28.00	44.00	96.00	67.00	94.00	88.00
growth rate		66.7%	-30.0%	-75.0%	600.0%	-42.9%	57.1%	118.2%	-30.2%	40.3%	-6.4%
Income Statement	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Sales	404.00	458.00	469.96	524.99	553.35	570.94	599.44	735.65	770.43	869.21	1,062.70
growth rate		13.4%	2.6%	11.7%	5.4%	3.2%	5.0%	22.7%	4.7%	12.8%	22.3%
Op.Income	10.00	30.00	57.37	45.05	72.79	82.86	87.57	141.65	115.95	120.19	106.63
growth rate		200.0%	91.2%	-21.5%	61.6%	13.8%	5.7%	61.8%	-18.1%	3.7%	-11.3%
IBT	25.70	48.40	35.21	43.98	62.20	74.21	65.56	134.11	107.75	110.43	97.87
growth rate		88.3%	-27.3%	24.9%	41.4%	19.3%	-11.7%	104.6%	-19.7%	2.5%	-11.4%
Net Income	10.00	30.00	23.15	26.00	38.49	44.53	31.25	96.09	65.82	73.19	68.97
growth rate		200.0%	-22.8%	12.3%	48.0%	15.7%	-29.8%	207.5%	-31.5%	11.2%	-5.8%
EPS	0.19	0.62	0.48	0.52	0.77	0.90	0.63	1.92	1.33	1.40	1.30
growth rate		226.3%	-22.6%	8.3%	48.1%	16.9%	-30.0%	204.8%	-30.7%	5.3%	-7.1%
Gross Profit	139.00	173.00	175.67	177.47	202.21	206.49	222.76	302.81	292.03	335.98	373.55
growth rate		24.5%	1.5%	1.0%	13.9%	2.1%	7.9%	35.9%	-3.6%	15.1%	11.2%

Quarterly Statements

Item Name	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Earnings BIT	26.89	42.55	19.57	19.37	21.21
growth rate		58.3%	-54.0%	-1.1%	9.6%
Balance Sheet	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Acct.Receivable	183.87	207.93	221.14	243.00	221.71
growth rate		13.1%	6.4%	9.9%	-8.8%
Acct.Payable	57.75	54.49	87.83	95.63	80.79
growth rate		-5.6%	61.2%	8.9%	-15.5%
Cur.Assets	333.11	352.03	370.78	434.05	411.09
growth rate		5.7%	5.3%	17.1%	-5.3%
Total Assets	1,683.95	1,767.98	1,790.81	1,867.21	1,930.23
growth rate		5.0%	1.3%	4.3%	3.4%
Cash	90.47	91.36	107.34	131.36	120.07
growth rate		1.0%	17.5%	22.4%	-8.6%
Inventory	21.06	20.27	20.64	22.99	29.38
growth rate		-3.8%	1.8%	11.4%	27.8%
Cur.Liabilities	364.56	355.56	398.35	508.77	474.35
growth rate		-2.5%	12.0%	27.7%	-6.8%
Liabilities	1,107.32	1,154.25	1,178.53	1,236.66	1,304.27
growth rate		4.2%	2.1%	4.9%	5.5%
LT Debt	565.27	589.51	587.08	534.97	631.90
growth rate		4.3%	-0.4%	-8.9%	18.1%
Equity	576.31	613.47	612.07	630.24	625.01
growth rate		6.5%	-0.2%	3.0%	-0.8%
Common Shares	53.74	53.74	53.74	53.74	53.74
growth rate		0.0%	0.0%	0.0%	0.0%
Cash Flow Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Capital Expenditures	4.53	12.04	6.06	7.70	5.64
growth rate		165.6%	-49.7%	27.1%	-26.8%
Cash Dividends	26.37	26.12	26.12	26.12	26.12
growth rate		-1.0%	0.0%	0.0%	0.0%
Cash From OA	7.80	31.68	41.98	83.83	-17.28
growth rate		306.1%	32.5%	99.7%	-100.0%
FCF	3.27	19.63	35.92	76.13	-22.92
growth rate		501.2%	82.9%	111.9%	-100.0%
Income Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Sales	248.89	285.60	291.40	262.52	276.96
growth rate		14.8%	2.0%	-9.9%	5.5%
Op.Income	26.89	42.55	19.57	19.37	21.21
growth rate		58.3%	-54.0%	-1.1%	9.6%
IBT	24.90	39.83	17.06	26.26	18.19
growth rate		60.0%	-57.2%	53.9%	-30.7%
Net Income	17.16	28.40	12.44	18.21	12.07
growth rate		65.5%	-56.2%	46.4%	-33.7%
EPS
growth rate
Gross Profit	83.59	111.56	97.52	89.55	91.03
growth rate		33.5%	-12.6%	-8.2%	1.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (70.46)

YOY Growth Grade:

D (38.64)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Dividend Yield: 1.3%
Beta: 1.03
Beta of 1.0321 suggests that the asset is volatile as the rest of the market (fairly priced).
PE: 79.92
EY: 1.3%
PEG: 2.55
PEG Ratio of 2.55 suggests that stock is overpriced.
PEGY: 2.45
PEGY Ratio of 2.45 suggests that stock is overpriced.
Price/BVPS: 8.47

Profitability Ratios

ROE: 11.0%
Return on Equity (ROE) of 11.0% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.
ROS: 10.0%
The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.
ROA: 5.5%
Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.
ROI: 16.0%
Return on Investment (ROI) of 16.0% suggests that a company is doing well.
ROIC: 4.9%
Return on Invested Capital (ROIC) of 4.9% suggests that a company may not be able to fund future growth from within.

Liquidity Ratios

Current Ratio: 0.93
Current Ratio of 0.93 suggests that a company may not be able to pay off bills as rapidly as it should.
Quick Ratio: 0.82
Quick Ratio of 0.82 suggests that a company may not be able to pay off bills as rapidly as it should.
Cash Turnover: -38.55
Turnover Of Cash Ratio of -38.55 suggests that a company may have funds tied up in short-term low-yielding assets or may have a cash surplus, which is not invested in the business.
Equity Ratio: 34.2%
Equity Ratio of 34.2% suggests that a company has high financing and debt service costs, not very attractive to investors.
Debt/Equity: 192.6%
Debt to Equity Ratio of 192.6% suggests that greater risk assumed by creditors, hence greater interest by them in the way the company is being managed.
Debt/FCF: 7.18
Debt/FCF of 7.18 suggests that a company does not have enough cash to pay off its long term debt within three years.

Efficiency Ratios

Avg Collection Period: 75.95
Average Collection Period of 75.95 days suggests a slow turnover, which may be the result of a number of bad accounts, or a tax collection policy or perhaps credit is being used to generate sales.
Inventory Turnover: 33.39
Inventory Turnover Ratio of 33.39 suggests that a company is doing well.
Cash Flow Ratio: 2.75
Cash Flow Ratio of 2.75 suggests a company is doing OK, but lower inventory is generally viewed as a positive trend.
Profit Margin: 6.5%

Value Price

PE and EPS

	Historical	Current	Forward
PE	32.45	83.12	16.42
EPS / Growth	37.6%	1.19	31.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 21.7%

Estimates	Pessimistic	Moderate	Optimistic
Rate of Return	15.0%
MOS Price %	50 %
Future EPS Growth	21.7%	30.2%	30.2%
Future PE	16.42	36.43	36.43
Future EPS	8.54	16.73	16.73
Value Price MOS %	34.64 -65.1%	150.63 51.8%	150.63 51.8%
MOS Price	17.32	75.31	75.31
IRT	14.04	11.37	11.37

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Graham Number: 17.74
Graham MOS: -82.1%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.